🟢 Royalty Pharma is trading 9.19% up in pre-market with no clear overnight catalyst

Royalty Pharma is trading 9.19% up at $64.00 in pre-market, based on the provided pre-market price, with no clear overnight announcement explaining the move.

• Royalty Pharma is scheduled to present at the Morgan Stanley 24th Annual Global Healthcare Conference on September 14, 2026; available coverage does not link the event to the surge.
• Broader markets are weaker, making a market-wide explanation unlikely. Confidence is low.